Where innovation and intelligence comes together.
Navigate the complexities of medical technology commercialisation with intelligent financial modelling and practical operational insight designed to ensure sustainable business leading results.
A focused approach that inspires transformational commercial outcomes.
Balancing commercial, operational and technical priorities with a clear value proposition that delivers sustainable business results in medical diagnostics and healthcare innovation is challenging.
To achieve this goal, you need a clearly defined strategic approach that is proven to open access to your target market, with the assurance that the commercial execution is aligned with market needs and meets the demands of different regulatory environments.
To enable you to commercialise your innovations and transform healthcare outcomes with sustainable success, Roopra Medical has the forward-thinking approach you need from a proven partner to deliver business results that inspire lasting change.
Bridging the gap between innovative medical technologies & commercial success.
Driving innovation forward with a measured outlook.
Defining the right path from initial concept development to market entry and expansion requires a measured outlook that balances financial, operational and technical aspects of product development to bridge the gap between medical innovation and commercial success.
To solve this problem, we provide end-to-end dedicated advisory support and expertise.
Marketing Guidance
Fundraising Support and Guidance
Turnkey Commercial Execution For Start-ups
Creavo Medical Technologies - Pathway Analysis & Value Proposition.
Creavo Medical Technologies developed an innovative magnetocardiography (MCG) platform for measuring the magnetic fields generated by the heart to enhance cardiac illness diagnosis.
Roopra Medical was engaged to evaluate the chest pain market, clinical pathways and diagnostic processes to determine the value proposition of the platform. The comprehensive analysis focused on tools used to diagnose NSTEMI myocardial infarction.
The team consulted with several clinical leaders in cardiology, emergency medicine and pathology to map the diagnostic pathways in different global regions. Using data from a variety of sources including NICE, chest pain protocols to provide UK-specific insights, Roopra Medical provided evidence that Creavo's technology could significantly improve cardiac pathways by efficiently ruling out patients without cardiac-related chest pain, resulting in significant time and cost savings.
These strategic insights helped Creavo Medical Technologies develop robust commercial plans, and Bob Roopra subsequently joined the company as Director of Business Development.
Sight Diagnostics - Commercial Strategy for Innovative Technology.
Sight Diagnostics introduced a revolutionary point-of-care hematology system using a cartridge-based optical approach, representing a significant advancement in the field.
Roopra Medical advised on the commercial strategy and go-to-market planning for the OLO product, working with the executive team, board of directors and key opinion leaders worldwide.
The strategic advice enabled Sight Diagnostics to successfully launch and create a new market space in emergency medicine, ambulatory care and oncology, leveraging the superior performance of their technology. The company achieved significant growth through this focused approach.
If everyone moves forward together, then success takes care of itself”
Henry Ford once said, "If everyone moves forward together, then success takes care of itself'. At Roopra Medical, we believe that the fundamentals behind a clear vision and strategy is the vital link that brings resources and energy together to enable our partners to solve their customers' problems and make great things happen in the modern marketplace.
As the founder of Roopra Medical, Bob is a seasoned leader with extensive national and global experience, adept at crafting and implementing successful business strategies for diverse organisations, from startups to multinationals. His approach integrates financial, operational, and technical expertise, driven by a vision for sustainable success, and he possesses specialised skills in executive management, commercialisation, and value proposition creation, underscored by his professional affiliations and scientific background.
Bob Roopra is a Fellow of the Chartered Institute of Management and former UK state registered in Haematology and Transfusion science.
Let’s talk...